| Emile Farhan |
Emile Farhan's career history includes current and former positions in the pharmaceutical industry. Currently, Emile is the Senior VP-Technical Operations & Quality Assurance at AVEO Pharmaceuticals, Inc. Previously, Emile held positions as the Director-Pharmaceutical Development at MGI PHARMA, Inc. from 2007 to 2008, Senior Director-Technical Operations at Veranova LP from 2000 to 2006, Senior Director-Product Development at Mersana Therapeutics, Inc., and Head-CMC Global Operations Coordination at Eisai Co., Ltd. from 2008 to 2011. Emile obtained a doctorate degree from Brandeis University and a graduate degree from the University of Massachusetts. |
| Michael Ferraresso |
Michael Ferraresso is currently the Chief Commercial Officer at AVEO Pharmaceuticals, Inc. He previously worked as the Vice President-Commercial at Infinity Pharmaceuticals, Inc. from 2013 to 2017. In 2017, he also briefly served as the Vice President-Commercial Operations at Verastem, Inc. Mr. Ferraresso completed his undergraduate degree at Assumption College. |
| Stefanie Solomon |
Stefanie Solomon is currently the Head-Compliance at AVEO Pharmaceuticals, Inc. Previously, she worked as a Member-FDA Regulatory Law Practice at Hogan Lovells US LLP. She completed her undergraduate degree at Duke University and her graduate degree at Harvard Law School. |
| Brent Gardner |
Brent Gardner currently works as an Executive Director-Medical Affairs at AVEO Pharmaceuticals, Inc. |
| Jinchul Jeong |
Jinchul Jeong currently works as a Chief Financial Officer at AVEO Pharmaceuticals, Inc. |
| Michael Smith |
Michael Smith currently works as the Head of Compliance and Regulatory Counsel at AVEO Pharmaceuticals, Inc. |
| Michael P. Bailey |
Michael P. Bailey currently works at AVEO Pharmaceuticals, Inc., as President & Chief Executive Officer from 2023 and IMV, Inc., as Chairman from 2022. Mr. Bailey also formerly worked at Genentech, Inc., as Member-Global Commercial Partnership Teams, ImClone LLC, as Senior Vice President-Commercial Operations from 1999 to 2008, and Synta Pharmaceuticals Corp., as Chief Commercial Officer & Senior Vice President from 2008 to 2010. Mr. Bailey received his undergraduate degree from St. Lawrence University and Masters Business Admin degree from Mendoza College of Business. |
| Corinne D. Epperly |
Corinne D. Epperly currently works at Sastra Cell Therapy, Inc., as Director from 2022 and IN8bio, Inc., as Independent Director from 2023. Dr. Epperly also formerly worked at AVEO Pharmaceuticals, Inc., as Independent Director from 2021 to 2023, Goldman Sachs International, as Research Analyst in 2010, Vascular Biogenics Ltd., as Chief Operating Officer from 2017 to 2018, Iovance Biotherapeutics, Inc., as Senior Vice President-Strategy & Operations from 2019 to 2020, and Cargo Therapeutics, Inc., as Chief Operating Officer from 2021 to 2023. Dr. Epperly received her undergraduate degree from the University of Virginia and graduate degree and doctorate degree from The University of North Carolina at Charlotte. |
